Racial Disparities in Pneumococcal Vaccination in Managed Care

This study has been completed.
Sponsor:
Collaborator:
Kaiser Permanente
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00229762
First received: September 28, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The goal of the study was to determine effectiveness of a telephone reminder to increase pneumococcal vaccination in a managed care population.


Condition Intervention
Pneumococcal Disease Prevention
Behavioral: phone call from nurses - informational only

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Educational/Counseling/Training
Official Title: Racial Disparities in Pneumococcal Vaccination in Managed Care: the Effects of Randomized Telephone Outreach

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • pneumococcal vaccination coverage

Estimated Enrollment: 7000
Study Start Date: March 2004
Estimated Study Completion Date: June 2005
Detailed Description:

Patients randomized to the intervention arm received a telephone call from managed care nurses asking about their pneumococcal vaccination status and whether they would like to be vaccinated. We compared six month follow-up of pneumococcal vaccination in electronic medical records for the intervention versus control group. We tested the percent vaccinated in each randomization arm using chi-square tests for proportions.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

- recommended for pneumococcal vaccination according to age or medical comorbidity

Exclusion Criteria:

- already known to have received pneumococcal vaccine

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00229762

Locations
United States, Georgia
Kaiser Permanente
Atlanta, Georgia, United States, 30333
Sponsors and Collaborators
Kaiser Permanente
Investigators
Principal Investigator: Carla A Winston, PhD Centers for Disease Control and Prevention
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00229762     History of Changes
Other Study ID Numbers: CDC-NIP-4252, 000HCJ4-2004-07797
Study First Received: September 28, 2005
Last Updated: September 28, 2005
Health Authority: United States: Federal Government

Keywords provided by Centers for Disease Control and Prevention:
pneumococcal vaccination coverage with no disease or efficacy outcomes recorded

ClinicalTrials.gov processed this record on July 23, 2014